Dechra introduces Sedadex to its anaesthesia and analgesia range - Veterinary Practice
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×

Dechra introduces Sedadex to its anaesthesia and analgesia range

Dechra Veterinary Products has added the sedation and premedication product Sedadex to its portfolio of anaesthesia and analgesia therapies

Sedadex, which has the active ingredient dexmedetomidine, is indicated for sedation and analgesia and for premedication prior to general anaesthesia in dogs and cats. It comes in a 10 ml vial and has a 56-day broached shelf life.

Claire Morgan, Brand Manager from Dechra said: “Sedadex is a highly selective α2 adrenoceptor agonist that is licensed for intravenous or intramuscular use in dogs and intramuscular injection in cats.

“It is a welcome addition to Dechra’s anaesthesia and analgesia range and compliments our existing therapies that include Comfortan, Sedator and Atipam

Veterinary Practice

Veterinary Practice is an online knowledge and information hub for veterinary professionals across all specialties. It provides reliable, useful and interesting content, written by expert authors and covering small animal, large animal, equine and practice management sectors of the veterinary surgeon and nursing professions.


More from this author

Have you heard about our
IVP Membership?

A wide range of veterinary CPD and resources by leading veterinary professionals.

Stress-free CPD tracking and certification, you’ll wonder how you coped without it.

Discover more